What does API do for pharmaceuticals & biologics?

We provide and connect you with the services and expertise needed for every stage of drug development.

At API, our teams understand the process of pharmaceutical development. We partner with life sciences companies at any stage of the research and development cycle, from CDMO services to clinical trials. As your strategic partner, API will provide access to facilities and experts that will help drive your pharmaceutical projects to successful commercialization. From molecule to market, our team is here to support your journey.

Services for Pharmaceuticals & Biologics

API offers strategic support through robust biostatistical analysis to extract meaningful insights and…

Combining scientific expertise, regulatory knowledge, and cutting-edge technology, API offers strategic support to…

Within these services, you can expect specialized support for pharmaceuticals (whether prescription or over-the-counter (OTC) drugs), within the specific domains relevant to the health regulator of your preference:

Regulatory Submissions and Applications

  • Clinical Trial Application (CTA) or New Drug Submission (NDS) – Health Canada
  • Investigational New Drug (IND)/ New Drug Application (NDA)/Biologics License Application (BLA) – FDA
  • Drug Master File (DMF)
  • And more

Drug Establishment Registration/Licensing

Grant Writing/Application

Programs for Pharmaceutical Innovators

Here are more resources to get your ideas to market.

In addition to services for the pharmaceutical industry, API has a suite of programs and training resources for innovators looking to commercialize their pharma & biologics ideas. Whether you’re looking for an incubator, network, or life sciences support and training for your business, check out our programs & training hub.

See all programs
API Team members

Stay up to date

Related news

See all news

Posted: Jan 20, 2025

    CUBEC Annual Conference 2025

    On January 25, The Canadian Undergraduate Biomedical Engineering Conference (CUBEC) is hosting the 2025 CUBEC Annual Conference to connect Canada’s brightest minds…

    Read moreabout CUBEC Annual Conference 2025
    Cubec poster

    Posted: Dec 18, 2024

    December Newsletter

    API Stories Teaming up with Edmonton’s Tech Leaders to Drive Regional Innovation  In November, our CEO, Andrew MacIsaac, represented API…

    Read moreabout December Newsletter
    Newsletter Header

    Get in touch

    Contact us today to learn how to propel your pharmaceutical or biologics projects with the support of our life sciences commercialization and drug development services in Canada.

    "*" indicates required fields

    This field is for validation purposes and should be left unchanged.